The Federal Government is listing a new form of fast-acting insulin, Fiasp Penfill, on the Pharmaceutical Benefits Scheme (PBS) from 1 October.

This will serve as a replacement for the original Fiasp medication that is being taken off the Scheme. 

Hear more highlights from Ben Fordham Livewith Mark Levy in the playlist below and give us a follow on Apple Podcasts: